What is Cellectar Biosciences Forward Dividend Yield %?
As of today (2024-04-25), the Forward Annual Dividend Yield of Cellectar Biosciences is 0.00%.
As of today (2024-04-25), the Trailing Annual Dividend Yield of Cellectar Biosciences is 0.00%.
CLRB's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.565 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Cellectar Biosciences's Forward Dividend Yield %
For the Biotechnology subindustry, Cellectar Biosciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellectar Biosciences's Forward Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cellectar Biosciences's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Cellectar Biosciences's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Cellectar Biosciences Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Cellectar Biosciences's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Cellectar Biosciences (Cellectar Biosciences) Business Description
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLRB has been successfully added to your